Rad regulation of CaV1.2 channels controls cardiac fight-or-flight response.

TitleRad regulation of CaV1.2 channels controls cardiac fight-or-flight response.
Publication TypeJournal Article
Year of Publication2022
AuthorsPapa A, Zakharov SI, Katchman AN, Kushner JS, Chen B-X, Yang L, Liu G, Jimenez ASanchez, Eisert RJ, Bradshaw GA, Dun W, Ali SR, Rodriques A, Zhou K, Topkara V, Yang M, Morrow JP, Tsai EJ, Karlin A, Wan E, Kalocsay M, Pitt GS, Colecraft HM, Ben-Johny M, Marx SO
JournalNat Cardiovasc Res
Volume1
Issue11
Pagination1022-1038
Date Published2022 Nov
ISSN2731-0590
Abstract

Fight-or-flight responses involve β-adrenergic-induced increases in heart rate and contractile force. In the present study, we uncover the primary mechanism underlying the heart's innate contractile reserve. We show that four protein kinase A (PKA)-phosphorylated residues in Rad, a calcium channel inhibitor, are crucial for controlling basal calcium current and essential for β-adrenergic augmentation of calcium influx in cardiomyocytes. Even with intact PKA signaling to other proteins modulating calcium handling, preventing adrenergic activation of calcium channels in Rad-phosphosite-mutant mice (4SA-Rad) has profound physiological effects: reduced heart rate with increased pauses, reduced basal contractility, near-complete attenuation of β-adrenergic contractile response and diminished exercise capacity. Conversely, expression of mutant calcium-channel β-subunits that cannot bind 4SA-Rad is sufficient to enhance basal calcium influx and contractility to adrenergically augmented levels of wild-type mice, rescuing the failing heart phenotype of 4SA-Rad mice. Hence, disruption of interactions between Rad and calcium channels constitutes the foundation toward next-generation therapeutics specifically enhancing cardiac contractility.

DOI10.1038/s44161-022-00157-y
Alternate JournalNat Cardiovasc Res
PubMed ID36424916
PubMed Central IDPMC9681059
Grant ListR01 HL160089 / HL / NHLBI NIH HHS / United States
S10 RR027050 / RR / NCRR NIH HHS / United States
T32 HL120826 / HL / NHLBI NIH HHS / United States
R01 HL151190 / HL / NHLBI NIH HHS / United States
R01 HL113136 / HL / NHLBI NIH HHS / United States
R01 HL155377 / HL / NHLBI NIH HHS / United States
R01 HL136758 / HL / NHLBI NIH HHS / United States
K08 HL153788 / HL / NHLBI NIH HHS / United States
R01 NS110672 / NS / NINDS NIH HHS / United States
R01 HL146149 / HL / NHLBI NIH HHS / United States
P30 CA013696 / CA / NCI NIH HHS / United States
F31 HL158232 / HL / NHLBI NIH HHS / United States
R01 HL121253 / HL / NHLBI NIH HHS / United States
K08 HL151969 / HL / NHLBI NIH HHS / United States
UL1 TR001873 / TR / NCATS NIH HHS / United States
K08 HL146964 / HL / NHLBI NIH HHS / United States
R01 HL140934 / HL / NHLBI NIH HHS / United States
R01 HL152236 / HL / NHLBI NIH HHS / United States
R01 HL138528 / HL / NHLBI NIH HHS / United States